325772-13-2

Upstream product

• 325772-11-0 2-tert-butyldimethylsilyl-5-[(1S,2S)-2-dibenzylamino-1,4-dihydroxybutyl]-N,N-dimethylimidazole-1-sulfonamide 
• 127927-61-1 (S)-2-dibenzylamino-γ-butyrolactone 
• 127927-62-2 (S)-3-Dibenzylamino-tetrahydro-furan-2-ol 
• 325772-17-6 2-tert-butyldimethylsilyl-5-[(2S,3S)-3-dibenzylaminotetrahydrofuran-2-yl]-N,N-dimethylimidazole-1-sulfonamide 
• 325772-12-1 4⁽⁵⁾-[(1S,2S)-2-dibenzylamino-1,4-dihydroxybutyl]imidazole 

Downstream Products

• 325772-14-3 (+)-tert-butyl 4-[(2S,3S)-3-dibenzylaminotetrahydrofuran-2-yl]imidazole-1-carboxylate 

Relevant academic research and scientific papers

Stereoselective synthesis of 4(5)-[(2S,3S)- and (2R, 3R)-3-aminotetrahydrofuran-2-yl)imidazoles using modified and standard mitsunobu cyclizations: Synthetic studies toward novel histamine H3-ligands

4(5)-[(2S,3S)-3-Aminotetrahydrofuran-2-yl)imidazole [(+)-3] and its enantiomer [(-)-(2R,3R)-3] were stereoselectivity synthesized by using both modified and standard Mitsunobu cyclizations from L- and D-methionine, respectively.